Karen L. Ling
Independent DirectorMs. Karen L. Ling, Esq, is a Director of Galderma Group AG since 2022. She served as an Independent Director at Bausch + Lomb Corporation since February 27, 2024 until August 5, 2026. She was Director of Mallinckrodt plc from August 12, 2022 until November 2023. She serves as Member of Advisory Committee at Galderma S.A. since March 01, 2022. She has a tremendous track record in executive roles at AIG, Allergan, Merck and Wyeth, guiding compensation, culture and program strategies that greatly improved shareholder relations and attracted and retained competitive talent. She is an accomplished global human resources executive with pharmaceutical industry experience. She has been a Director of iRhythm Holdings, Inc. (formerly known as iRhythm Technologies, Inc.) since November 1, 2021. She served as Independent Director at TherapeuticsMD, Inc. since April 16, 2020 until 2023. She had been Executive Vice President and Chief Human Resources Officer of American International Group, Inc. since July 2019 until May 2021. From March 2015 until July 2019, she served as Executive Vice President and Chief Human Resources Officer at Allergan plc she unified multiple, successive acquisitions. She was also instrumental in various innovative compensation programs for the executive leadership team, focused on increasing shareholder value. Ms. Ling served as Chief Human Resources Officer and Senior Vice President of Forest Laboratories, Inc. since January 21, 2014 until July 2014. From July 2014 until March 2015, Ms. Ling served as Senior Vice President, Human Resources and Chief Human Resources Officer at Actavis plc. Ms. Ling served as Senior Vice President, Human Resources, for Merck & Co. Inc.'s Global Human Health and Consumer Care businesses worldwide from 2011 until January 2014. She was Vice President, Compensation and Benefits at Merck from November 2009 until 2011. Prior to Merck, she served as Group Vice President, Global Compensation & Benefits at Schering-Plough from May2008 until November 2009. Ms. Ling spent several years at Wyeth in various positions of responsibility in human resources for the pharmaceutical, vaccines and consumer health commercial businesses. She also worked in Wyeth Pharmaceutical's Labor and Employment Department. Prior to joining Wyeth, she practiced corporate law with Goldstein and Manello, P.C. in Boston. In addition, she sits on the Board of two non-profit organizations, ExpandED and the JED Foundation. Ms. Ling holds a B.A. in Economics from Yale University and a J.D. from Boston University School of Law. She was Independent Director of Bausch & Lomb Incorporated from February 2024 to 2026.
Positions
- Company NameiRhythm Holdings, Inc.Stock CodeIRTCPositionIndependent DirectorColleagues
- QSQuentin S. BlackfordPresident, CEO & Director
- AYAbhijit Y. TalwalkarIndependent Chairman
- DGDaniel G. WilsonCFO & Principal Financial Officer
- MPMinang P. TurakhiaChief Medical & Scientific Officer and Executive VP of Advanced Technologies
- PMPatrick Michael MurphyChief Business & Legal Officer
- CMChad M. PattersonChief Commercial and Product Officer
- BGBruce George BodakenIndependent Director
- KKKaren K. McGinnisIndependent Director
